Viewing Study NCT03552718


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:57 AM
Study NCT ID: NCT03552718
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-17
First Post: 2018-05-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
Sponsor: NantBioScience, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module